MAPK3 and cancer: Moreover, the expression of the PrPC protein has been shown to enhance the adhesive, invasive, and metastatic abilities of cancer cells through the activation of the ERK1/2 signaling pathway and transactivation of MMP11, a metalloproteinase responsible for extracellular matrix (ECM) degradation in cancer [34,36].